Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2023 third-quarter earnings
A cartoon displaying multiple different types of charts and graphs

What you need to know about Johnson & Johnson’s 2023 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.

This morning, Johnson & Johnson shared its third-quarter 2023 performance.

Since its founding in 1886, the company has grown to become the world’s largest, most diversified healthcare products company, with more than 130,000 employees across the globe working every day to help change the trajectory of health for humanity.

This Q3 2023 infographic further highlights how Johnson & Johnson continues to progress its long-term operational and financial priorities and deliver value to its stakeholders.

“We are confident that Johnson & Johnson’s strong performance through the first nine months of this year will continue, and as a result, we have increased our guidance for 2023,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “The strength of our business, the promise of our Innovative Medicine and MedTech pipelines, and our 130,000 colleagues around the world position us well for long-term growth and significant value creation for shareholders.”

For more details about the company’s 2023 third-quarter results, and to read a message from Chairman of the Board and Chief Executive Officer Joaquin Duato, here’s an infographic that highlights key stats.


Johnson & Johnson 2023 Q3 Earnings infographic

Johnson & Johnson’s 2023 3rd-Quarter Earnings

Read the earnings press release, which includes full financial data for the third quarter of 2023.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.